Nakagawa, Takayuki <br/><br/>
E7050: a dual c-Met and VEGFR-2 tyrosine kinase inhibitor promotes tumor regression and prolongs survival in mouse xenograft models.  [electronic resource] 

 -  Cancer science  Jan 2010 
 - 210-5 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1349-7006 
<br/><br/><label>Standard No.: </label>10.1111/j.1349-7006.2009.01343.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aminopyridines--therapeutic use<br/>Animals<br/>Antineoplastic Agents--therapeutic use<br/>Cell Line, Tumor<br/>Disease Progression<br/>Female<br/>Humans<br/>Mice<br/>Neoplasms, Experimental--drug therapy<br/>Phosphorylation<br/>Piperazines--therapeutic use<br/>Protein Kinase Inhibitors--therapeutic use<br/>Proto-Oncogene Proteins c-met--antagonists & inhibitors<br/>Vascular Endothelial Growth Factor Receptor-2--antagonists & inhibitors<br/>Xenograft Model Antitumor Assays